Literature DB >> 18056342

Inverse Rap1 and phospho-ERK expression discriminate the maintenance phase of tolerance and priming of antigen-specific CD4+ T cells in vitro and in vivo.

Angela M Morton1, Barbara McManus, Paul Garside, Allan McI Mowat, Margaret M Harnett.   

Abstract

T cell recognition of Ag can result in priming or tolerance depending on the context in which Ag is recognized. Previously, we have reported that these distinct functional outcomes are associated with marked differences in the amplitude, kinetics, and cellular localization of activated, pERK signals at the level of individual Ag-specific T cells in vitro. Here, we show that the GTPase Rap1, which can antagonize the generation of such pERK signals and has been reported to accumulate in tolerant cells, exhibits an inverse pattern of expression to pERK in individual Ag-specific primed and tolerized T cells. Although pERK is expressed by more primed than tolerized T cells when rechallenged with Ag in vitro, Rap1 is expressed by higher percentages of tolerant compared with primed Ag-specific T cells. Moreover, whereas pERK localizes to the TCR and lipid rafts in primed cells, but exhibits a diffuse cellular distribution in tolerized cells, Rap1 colocalizes with the TCR and lipid raft structures under conditions of tolerance, but not priming, in vitro. This inverse relationship between Rap1 and pERK expression is physiologically relevant, given that we observed the same patterns in Ag-specific T cells in situ, following induction of priming and tolerance in vivo. Together, these data suggest that the maintenance of tolerance of individual Ag-specific T cells may reflect the recruitment of up-regulated Rap1 to the immune synapse, potentially resulting in sequestration of Raf-1 and uncoupling of the TCR from the Ras-ERK-MAPK cascade.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056342     DOI: 10.4049/jimmunol.179.12.8026

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Characterization of CD4+ T-cell-dendritic cell interactions during secondary antigen exposure in tolerance and priming.

Authors:  Catherine M Rush; Owain R Millington; Sharon Hutchison; Karen Bryson; James M Brewer; Paul Garside
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

2.  The helminth product ES-62 protects against septic shock via Toll-like receptor 4-dependent autophagosomal degradation of the adaptor MyD88.

Authors:  Padmam Puneet; Mairi A McGrath; Hwee Kee Tay; Lamyaa Al-Riyami; Justyna Rzepecka; Shabbir M Moochhala; Shazib Pervaiz; Margaret M Harnett; William Harnett; Alirio J Melendez
Journal:  Nat Immunol       Date:  2011-02-27       Impact factor: 25.606

3.  MEKK3 regulates IFN-gamma production in T cells through the Rac1/2-dependent MAPK cascades.

Authors:  Xiaofang Wang; Fan Zhang; Fanping Chen; Dou Liu; Yi Zheng; Yongliang Zhang; Chen Dong; Bing Su
Journal:  J Immunol       Date:  2011-04-06       Impact factor: 5.422

4.  Receptor cross-talk spatially restricts p-ERK during TLR4 stimulation of autoreactive B cells.

Authors:  Sang-Ryul Lee; Jennifer A Rutan; Andrew J Monteith; Shannon Z Jones; Sun Ah Kang; Kristen N Krum; Michelle A Kilmon; Jose R Roques; Nikki J Wagner; Stephen H Clarke; Barbara J Vilen
Journal:  J Immunol       Date:  2012-09-14       Impact factor: 5.422

5.  Human neonatal naive CD4+ T cells have enhanced activation-dependent signaling regulated by the microRNA miR-181a.

Authors:  Amy C Palin; Vasavi Ramachandran; Swati Acharya; David B Lewis
Journal:  J Immunol       Date:  2013-02-13       Impact factor: 5.422

6.  Differential distribution of both IL-12Rbeta chains in the plasma membrane of human T cells.

Authors:  Ana Canda-Sánchez; Francisco J Salgado; Amparo Pérez-Díaz; Carla Varela-González; Pilar Arias; Montserrat Nogueira
Journal:  J Membr Biol       Date:  2008-12-09       Impact factor: 1.843

7.  The helminth product, ES-62, protects against airway inflammation by resetting the Th cell phenotype.

Authors:  Justyna Rzepecka; Ivonne Siebeke; Jennifer C Coltherd; Dorothy E Kean; Christina N Steiger; Lamyaa Al-Riyami; Charles McSharry; Margaret M Harnett; William Harnett
Journal:  Int J Parasitol       Date:  2013-01-03       Impact factor: 3.981

8.  Prophylactic and therapeutic treatment with a synthetic analogue of a parasitic worm product prevents experimental arthritis and inhibits IL-1β production via NRF2-mediated counter-regulation of the inflammasome.

Authors:  Justyna Rzepecka; Miguel A Pineda; Lamyaa Al-Riyami; David T Rodgers; Judith K Huggan; Felicity E Lumb; Abedawn I Khalaf; Paul J Meakin; Marlene Corbet; Michael L Ashford; Colin J Suckling; Margaret M Harnett; William Harnett
Journal:  J Autoimmun       Date:  2015-05-11       Impact factor: 7.094

9.  Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.

Authors:  Brian T Fife; Kristen E Pauken; Todd N Eagar; Takashi Obu; Jenny Wu; Qizhi Tang; Miyuki Azuma; Matthew F Krummel; Jeffrey A Bluestone
Journal:  Nat Immunol       Date:  2009-09-27       Impact factor: 25.606

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.